par Gonzalez-Duque, Sergio;Azoury, Marie Eliane;Colli, Maikel Luis ;Afonso, Georgia;Turatsinze, Jean Valéry ;Nigi, Laura;Lalanne, Ana Ines;Sebastiani, Guido;Carré, Alexia;Pinto, Sheena;Culina, Slobodan;Corcos, Noémie;Bugliani, Marco;Marchetti, Piero;Armanet, Mathieu;Diedisheim, Marc;Kyewski, Bruno;Steinmetz, Lars L.M.;Buus, Søren;You, Sylvaine;Dubois-Laforgue, Daniele;Larger, Etienne;Beressi, Jean Paul;Bruno, Graziella;Dotta, Francesco;Scharfmann, Raphaël;Eizirik, Decio L. ;Verdier, Yann;Vinh, Joëlle;Mallone, Roberto
Référence Cell Metabolism, 28, 6, page (946-960.e6)
Publication Publié, 2018-12-01
Référence Cell Metabolism, 28, 6, page (946-960.e6)
Publication Publié, 2018-12-01
Article révisé par les pairs
Résumé : | Mallone et al. use peptidomics and transcriptomics to identify the epitopes presented by β cells that trigger type 1 diabetes (T1D) autoimmunity. Multiple pathways, including conventional processing and mRNA and peptide splicing, are involved in epitope generation and presentation; these epitopes are selectively recognized by pancreas-infiltrating CD8+ T lymphocytes in T1D patients. |